PCRI’s moderator, Mark Moyad, MD, MPH, asks Laurence Klotz, MD, about TULSA-PRO, a recently developed form of therapy that uses real-time MR imaging and ultrasound waves to thermally ablate prostate tissue. Studies are ongoing, but the hope is that this therapy will be used for partial-gland ablation and that the real-time MR imaging will provide greater precision than its closest comparable treatment, HIFU.